dRx Capital Novartis Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
43
- Portfolio
-
21
- Exits
-
5
dRx Capital Novartis General Information
Company Description
Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland. The firm seeks to invest in healthcare, artificial intelligence and machine learning, big data, research and development optimization, patient care, and pharma supply chain and commercialization sectors.
Business Details
Website
www.drxcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Novartis Campus
- 4056 Basel
- Switzerland
dRx Capital Novartis Investments (43)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Yseop | 05-Dec-2023 | PE Growth/Expansion | Business/Productivity Software | Profitable | ||
| Octave | 26-Jul-2023 | Decision/Risk Analysis | Generating Revenue | |||
| RxLightning | 24-May-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Holmusk | 06-Jan-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| H1 (Healthcare Technology Systems) | 09-Jun-2022 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Peptone | 09-Jun-2022 | Biotechnology | Pre-Clinical Trials | |||
| Koneksa | 07-Feb-2022 | Discovery Tools (Healthcare) | Clinical Trials - General | |||
| NuvoAir Medical | 19-Jan-2022 | Clinics/Outpatient Services | Generating Revenue | |||
| Pear Therapeutics | 03-Dec-2021 | PIPE | Other Healthcare Technology Systems | Bankruptcy: Admin/Reorg | ||
| Cala Health | 16-Nov-2021 | Later Stage VC | Therapeutic Devices | Generating Revenue |
dRx Capital Novartis Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Science 37 Holdings | 11-Mar-2024 | Merger/Acquisition | |
| Pear Therapeutics | 03-Dec-2021 | ||
| Science 37 Holdings | 06-Oct-2021 | ||
| Aspen RxHealth | Merger/Acquisition | ||
| Vineti | Out of Business |
dRx Capital Novartis Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
dRx Capital Novartis Co-Investors (141)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| McKesson Ventures | 5 |
|
|
||
| Novartis Pharma |
|
|
|||
| Novartis |
|
|
|||
| S32 |
|
|
|||
| Hikma Ventures |
|
|
dRx Capital Novartis FAQs
-
What is dRx Capital Novartis?
Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland.
-
When was dRx Capital Novartis founded?
dRx Capital Novartis was founded in 2015.
-
Where is dRx Capital Novartis headquartered?
dRx Capital Novartis is headquartered in Basel, Switzerland.
-
What is dRx Capital Novartis's total asset value?
dRx Capital Novartis has around in total assets under management.
-
How many investments has dRx Capital Novartis made?
dRx Capital Novartis has made 43 investments.
-
What has dRx Capital Novartis invested in?
dRx Capital Novartis has made numerous investments in companies like Yseop, Octave, and RxLightning within the Business/Productivity Software, Decision/Risk Analysis, and Enterprise Systems (Healthcare) industries.
-
What has dRx Capital Novartis invested in recently?
dRx Capital Novartis's latest investment was on 05-Dec-2023 in Yseop, a company within the Business/Productivity Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
